Cocrystal Pharma (COCP) Asset Writedowns and Impairment (2010 - 2022)
Cocrystal Pharma (COCP) reported Asset Writedowns and Impairment of $19.1 million for Q2 2022, down 79.33% sequentially from $92.4 million in Q4 2016.
Cocrystal Pharma (COCP) Asset Writedowns and Impairment (2010 - 2022) Analysis & Trends
Cocrystal Pharma (COCP) has 7 years of Asset Writedowns and Impairment data on file, last reported at $19.1 million in Q2 2022.
- For the quarter ending Q2 2022, Asset Writedowns and Impairment changed N/A year-over-year to $19.1 million; the trailing twelve-month figure through Dec 2022 stood at $111.5 million (changed N/A YoY), and the FY2022 full-year result was $19.1 million, changed N/A from the prior year.
- Asset Writedowns and Impairment declined to $19.1 million in Q2 2022, from $92.4 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $19.1 million in Q2 2022 to a low of $19.1 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 19.09 Mn |
| Jun 30, 2022 | 19.09 Mn |
| Dec 31, 2016 | 92.37 Mn |
| Dec 31, 2016 | 92.37 Mn |
| Dec 31, 2015 | 38.67 Bn |
| Dec 31, 2015 | 38.67 Bn |
| Mar 31, 2013 | 16,667.00 |
| Mar 31, 2013 | 16,667.00 |
| Dec 31, 2012 | 306,115.00 |
| Dec 31, 2012 | 306,115.00 |
| Sep 30, 2012 | 50,000.00 |
| Sep 30, 2012 | 50,000.00 |
| Jun 30, 2012 | 40,803.00 |
| Jun 30, 2012 | 40,803.00 |
| Mar 31, 2012 | 9,000.00 |
| Mar 31, 2012 | 9,000.00 |
| Dec 31, 2011 | 301,456.00 |
| Dec 31, 2011 | 301,456.00 |
| Sep 30, 2011 | 9,000.00 |
| Sep 30, 2011 | 9,000.00 |